The estimated Net Worth of Mark N. Diker is at least $1.33 Milion dollars as of 17 January 2020. Mark Diker owns over 2,000 units of Cantel Medical Corp stock worth over $81,620 and over the last 7 years Mark sold CMD stock worth over $1,251,150.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mark Diker CMD stock SEC Form 4 insiders trading
Mark has made over 3 trades of the Cantel Medical Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently Mark bought 2,000 units of CMD stock worth $124,860 on 17 January 2020.
The largest trade Mark's ever made was selling 7,000 units of Cantel Medical Corp stock on 3 October 2017 worth over $692,300. On average, Mark trades about 1,167 units every 70 days since 2017. As of 17 January 2020 Mark still owns at least 1,000 units of Cantel Medical Corp stock.
You can see the complete history of Mark Diker stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Mark Diker's mailing address?
Mark's mailing address filed with the SEC is 570 LEXINGTON AVE, , NEW YORK, NY, 10022.
Insiders trading at Cantel Medical Corp
Over the last 9 years, insiders at Cantel Medical Corp have traded over $17,499,798 worth of Cantel Medical Corp stock and bought 37,750 units worth $1,679,440 . The most active insiders traders include Anthony B Evnin, Karen Prange a Charles M Diker. On average, Cantel Medical Corp executives and independent directors trade stock every 39 days with the average trade being worth of $640,554. The most recent stock trade was executed by Ann E Berman on 5 April 2021, trading 5,500 units of CMD stock currently worth $453,255.
What does Cantel Medical Corp's logo look like?
Complete history of Mark Diker stock trades at Cantel Medical Corp
Cantel Medical Corp executives and stock owners
Cantel Medical Corp executives and other stock owners filed with the SEC include:
-
George L. Fotiades,
CEO, Vice Chairman & Member of Office of the Chairman -
Peter G. Clifford,
Pres & COO -
Seth M. Yellin,
Exec. VP of Strategy & Corp. Devel. -
Shaun M. Blakeman,
Sr. VP, CFO & Member of Office of the Chairman -
Charles Michael Diker,
Chairman & Member of Office of the Chairman -
Jeffrey Z. Mann,
Sr. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman -
Jean M. Casner,
Sr. VP & Chief HR Officer -
Milicent Brooks,
Head of Corp. Communications -
Ryan Lada,
VP of Investor Relations -
Michael Drexel,
CTO & Sr. VP -
Jean Casner,
SVP and CHRO -
Dorothy A Donnelly Brienza,
-
Eric W Nodiff,
EVP and General Counsel -
Anthony B Evnin,
Director -
Steven C Anaya,
SVP; Chief Accounting Officer -
Mark N. Diker,
Director -
Laura L Forese,
Director -
Alan R Batkin,
Director -
Ronnie Myers,
Director -
Ann E Berman,
Director -
Brian Capone,
SVP and Princ. Accounting Ofr -
Jorgen B Hansen,
President and CEO -
Seth M Yellin,
Executive Vice President -
Peter Pronovost,
Director -
Lawrence Conway,
Senior Vice President -
Shaun M. Blakeman,
SVP - CFO -
Jeffrey Z Mann,
SVP, General Counsel -
Karen Prange,
Director -
George L Fotiades,
Chief Executive Officer -
Peter G Clifford,
President and COO -
Charles M Diker,
Chairman